ShockWave Medical, Inc. (SWAV)

ShockWave Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	281.67	328.42	156.59	89.21	50.42	139.05
Short-Term Investments	747.56	662.13	147.91	111.77	151.93	56.3
Cash & Cash Equivalents	1,029	990.55	304.49	200.98	202.35	195.35
Cash Growth	146.90%	225.31%	51.50%	-0.68%	3.59%	392.77%
Receivables	124.44	114.55	71.37	37.44	11.69	7.38
Inventory	111.22	107.59	75.11	42.98	29.86	12.07
Other Current Assets	10.46	12.57	8.29	4.51	2.4	1.9
Total Current Assets	1,275	1,225	459.26	285.9	246.3	216.7
Property, Plant & Equipment	113.61	98.63	80.52	51.86	23.93	13.74
Long-Term Investments	2.36	1.64	3.51	5.99	0	0
Goodwill and Intangibles	131.53	132.43	0	0	0	0
Other Long-Term Assets	120.9	108.61	102.8	1.94	1.81	1.51
Total Long-Term Assets	368.4	341.3	186.83	59.78	25.74	15.24
Total Assets	1,644	1,567	646.09	345.68	272.04	231.94
Accounts Payable	9.84	8.87	6.72	3.52	1.47	2.79
Current Debt	0	0	0	5.5	3.3	6.67
Other Current Liabilities	82.49	95.34	56.65	42.61	20.82	14.55
Total Current Liabilities	92.33	104.21	63.37	51.63	25.58	24.01
Long-Term Debt	773.15	766.97	59.13	39.95	20.81	15.28
Other Long-Term Liabilities	26.51	26.72	12.27	12.27	0	0
Total Long-Term Liabilities	799.66	793.68	71.4	52.22	20.81	15.28
Total Liabilities	891.99	897.89	134.77	103.85	46.39	39.29
Total Debt	773.15	766.97	59.13	45.45	24.11	21.94
Debt Growth	459.08%	1197.17%	30.09%	88.54%	9.86%	45.81%
Retained Earnings	165.81	110.47	-36.81	-252.81	-243.67	-177.97
Comprehensive Income	-0.11	0.29	-0.87	-0.2	0.01	0.04
Shareholders' Equity	751.76	668.68	511.32	241.83	225.65	192.65
Net Cash / Debt	256.09	223.59	245.37	155.53	178.25	173.41
Net Cash / Debt Growth	-8.07%	-8.88%	57.76%	-12.74%	2.79%	605.10%
Net Cash Per Share	6.66	5.85	6.48	4.43	5.39	7.25
Working Capital	1,183	1,121	395.89	234.27	220.72	192.69
Book Value Per Share	20.16	18.22	14.24	6.89	6.82	8.06

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).